|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/04 | |
| A61K 31/553 | |||
| A61P 35/00 |
| (11) | Number of the document | 3317283 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16733104.0 |
| Date of filing the European patent application | 2016-07-01 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/065496 |
| Date | 2016-07-01 |
| (87) | Number | WO 2017/001658 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 201562188018 P | 2015-07-02 | US | |
| 201562205127 P | 2015-08-14 | US |
| (72) |
BRAUN, Marie-Gabrielle, US
HANAN, Emily, US
STABEN, Steven T., US
ELLIOTT, Richard, GB
HEALD, Robert Andrew, GB
MACLEOD, Calum, GB
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE |
| BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE |